With about 70 percent of the world's people having taken a particular drug, researchers can now go in, parse the data, and see whether there were any differences (at a society wide level) between those who took it, and those who didn't.
For less than the cost of a candy bar, access REAL, UNCENSORED news with The Epoch Times. Just $1 for 6 months lets you explore genuine stories and insights missed by mainstream media, all in one place.
Approximately 5.5 billion people across the planet have received some form of the COVID vaccine—with about 2.5 billion people not having received the vaccine. Numbers like these represent not only the biggest pharmaceutical push in world history, but also, it presents a really ripe opportunity for data analytics.
With about 70 percent of the world's people having taken a particular drug, researchers can now go in, parse the data, and see whether there were any differences (at a society-wide level) between those who took it and those who didn't.
The U.S. Supreme Court made a decision Tuesday that was quite surprising to most people who follow the court closely.
Despite overturning affirmative action in June 2023, the court declined to hear an appeal by an organization that had filed a federal lawsuit against a local school board, alleging that the board's policy changes directly discriminated against Asian Americans.
"What the study shows is that when you put a pseudouridine in where a uridine should be, the ribosome jumps or misreads messenger RNA. And as a consequence of this, it results in a bogus protein being made. So instead of making spike protein, it makes a nonsense protein that is possibly toxic."
"There's no one reading this paper who couldn't understand what a fundamental disaster this actually is because it challenges the whole premise of the mRNA platform," says Dr. Paul Marik.
The Supreme Court unanimously overturned a federal appeals court, finding that under U.S. admiralty law, a forum selection provision in an insurance policy must be followed.
Signs of recovery from Alzheimer's dementia and other neurological disorders are being shown by patients on plasmalogen and other targeted-nutrient therapies. Plasmalogen is a phospholipid essential to brain, lung, and heart function.
Dayan Goodenowe identifies low plasmalogen as the prime cause of Alzheimer's disease, as well as a leading cause of amyotrophic lateral sclerosis (also known as ALS, or Lou Gehrig's disease), autism, and other neurological disorders.
EpochTV delivers the cutting-edge investigative journalism you have come to expect from The Epoch Times. We dig deep every day to give you the real facts that make real news.
0 komentar:
Post a Comment